Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development

There are few novel therapeutic options available for companion animals, and medications rely heavily on repurposed drugs developed for other species. Considering the diversity of species and breeds in companion animal medicine, comprehensive PK exposures in the companion animal patient is often lac...

Descripción completa

Detalles Bibliográficos
Autores principales: McReynolds, Cindy B., Yang, Jun, Guedes, Alonso, Morisseau, Christophe, Garcia, Roberto, Knych, Heather, Tearney, Caitlin, Hamamoto, Briana, Hwang, Sung Hee, Wagner, Karen, Hammock, Bruce D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399023/
https://www.ncbi.nlm.nih.gov/pubmed/34443621
http://dx.doi.org/10.3390/molecules26165034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399023/
https://www.ncbi.nlm.nih.gov/pubmed/34443621
http://dx.doi.org/10.3390/molecules26165034

Ejemplares similares